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Abstract 
Iron deficiency causes disbalance of other micro- and macroelements that leads to 
disruption of the exchange of most micronutrients and development of characteristic 
clinical symptoms. Interaction and correlation between trace elements and 
haematological parameters is still not clear. Aim. To investigate the relationship between 
haematological parameters, biochemical markers of iron metabolism and trace elements 
in children under 3 years with Iron-deficiency anaemia (IDA). Materials and Methods. 
Investigation comprises 86 patients from 0 to 3 years of age with clinical and laboratory 
signs of IDA. 38 children-patients are of the University Hospital, Medical University – 
Pleven, Bulgaria – I group, and 48 are patients of the Sumy Regional Child’s Clinical 
Hospital, Sumy, Ukraine – II group. Comparison group includes 25 healthy children at 
the same age. Haematological parameters and the red cell indices were examined by 
analyzer MICROS – 18 (ABX). The serum erythropoietin (sEPO) and ferritin (sFR) 
levels were determined by ELISA. Serum content of trace elements was determined  
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spectrophotometrically (I group) or by atomic absorption 
spectrophotometry (II group). To evaluate a relationship 
between markers of iron metabolism and haematological 
parameters we have used Spearman's correlation coefficients. 
Results. Formation of IDA is caused not only by violation of 
iron metabolism, but also other trace elements that directly or 
indirectly may affect both iron exchange and erythropoiesis 
regulation through the erythropoietin production. We found 
significant correlations between the level of chromium and 
transferrin saturation (r = -0.382, p = 0.018), zinc – with 
sEPO (r = 0.543, p = 0.036), copper – with sFR (r = -0.561, p 
= 0.029), and sEPO (r = -0.739, p = 0.0016), and cobalt – 
with sEPO (r = 0.769, p = 0.0021), that indicate the role of 
trace elements in the pathogenesis of IDA. Thus, if the 
routine therapy of IDA is ineffective, a concomitant 
micronutrient disorder should be considered, with an 
evaluation of trace elements level, and, if necessary, a 
correction should be carried out. 
1. Introduction 
Iron-deficiency anaemia (IDA) is the most common form of 
anaemia worldwide [1]. Causes of iron deficiency include poor 
iron intake, chronic blood loss, impaired absorption, or any 
combination of the three [2]. Iron-deficiency anaemia accounts 
for approximately one-half of anaemia cases [4]. The global 
prevalence of anaemia is 24.8% and 1.62 billion people are 
affected. The highest prevalence is in preschool-aged children 
– 47.4% worldwide, but Africa and Asia have the highest 
prevalence of anaemia among this category – 64.6% and 
58.0%, respectively [3]. Despite WHO initiative, global 
incidence of IDA had not decreased during last decade [1]. 
Iron deficiency is probably the most common deficiency in 
children both in developing and industrialized nations. Iron is 
a key micronutrient in IDA pathogenesis and prognosis, but 
iron deficiency causes disbalance of other micro- and 
macroelements that leads to disruption of the exchange of 
most micronutrients and development of characteristic 
clinical symptoms. Iron, zinc, copper, etc. are some of the 
inorganic elements that are necessary for normal growth and 
sustained biological activities [5]. 
The role of some micronutrients in IDA is still not 
completely discovered, as well as their relationship. Zinc (Zn) 
is essential for normal iron metabolism, influences the 
growth and affects the development and integrity of the 
immune system [6]. Many studies have shown that zinc 
deficiency can cause T-cell dysfunction and impair cellular 
immune functions [7, 8]. Also zinc, as well as copper, is 
cofactor of the antioxidant enzyme, superoxide dismutase, 
which detoxifies the toxic superoxide radical [9]. Some data 
show decreased serum zinc levels during IDA [10, 11], but 
another report about normal zinc level in these patients [12]. 
Also some experimental data show low iron concentration in 
organs and blood during zinc deficiency [13]. But study of 
iron supplementation among anaemic patients finds 
effectively increased iron status while adding zinc to iron 
supplementation [14]. The administration of zinc along with 
iron presumably increases production of proteins and globin 
related to haematopoiesis in the bone marrow [15]. In case of 
iron deficiency, a zinc ion is alternately incorporated into the 
porphyrin ring complex of haemoglobin, thereby increasing 
the concentration of zinc protoporphyrin. That’s why zinc 
protoporphyrin may be an indicator for the assessment of 
iron status [16]. 
Copper (Cu) plays vital role as a structural and catalytic 
component of metalloenzymes, it is an essential nutrient 
required for growth and development [17], and it is needed to 
absorb and utilize iron [18]. The characteristic 
haematological effects of copper deficiency are anaemia, 
both microcytic, normocytic or macrocytic, neutropenia [19], 
and more rarely ‒ thrombocytopenia [20]. The peripheral 
blood and bone marrow aspirate findings in copper 
deficiency can mimic myelodysplastic syndrome [21]. But 
there are different data about the Cu level during the IDA. 
Turgut et al. have not found significant differences of Cu 
blood concentration in children with IDA [22], while Ece et 
al. report about elevation of copper level in comparison to 
non-anaemic patients [23]. However, a lot of researchers 
show decreasing Cu level in children with IDA [5, 24, 25]. 
The biological function of chromium (Cr) is not fully 
known yet. Cr interacts with the thyroid metabolism in 
humans and stimulate the DNA-dependant RNA synthesis 
[26]. Cr acts with insulin on the first step in the metabolism 
of sugar entry into the cell, and facilitates the interaction of 
insulin with its receptor on the cell surface. Cr has a lot of 
interactions with some metals, for example Zn, and vanadium 
and iron supplementation has been shown to decrease the 
absorption of Cr [27]. On the other hand, absorption of Cr 
was elevated in Zn-deficient rats and was reduced by zinc 
supplementation [28]. The interaction between Cr and iron is 
not completely understood, but some data show iron 
deficiency in patients with high Cr intake [29]. 
Cobalt (Co) is a key constituent of cobalamin, also known 
as vitamin B12, which is the primary biological reservoir of 
this metal. Also Co can stimulate erythropoietin in kidney 
and maintains red blood cell production. Lack of Co causes 
vitamin B12 deficiency anaemia. But there is few information 
about Co level in IDA, and some authors report about higher 
blood concentrations of Co and cadmium in patient with low 
iron stores [30]. 
Nickel (Ni) is one of the essential elements for mammals 
[31]. Khan and Moheman (2006) report that nickel interacts 
with iron found in the haemoglobin, helps in the oxygen 
transport, and stimulates the metabolism. It is regarded as a 
key metal in several plants and animal enzyme systems. 
Nickel is involved in the transmission of genetic code (DNA, 
RNA), and it is also present in certain enzyme systems that 
metabolize sugars. Schnegg and Kirchgessner [32] report that 
nickel deficiency in rats led to reduced iron content in organs, 
reduced haemoglobin and haematocrit values, and anaemia. 
But there are no data about Ni concentrations in the organism 
of anaemic children, as well as their correlations with 
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haematological parameters. 
Thus, a lot of trace elements play key roles in the 
pathogenesis of IDA, due to synergism and antagonism with 
iron. But their interactions and correlations with 
haematological parameters are still not clear. 
The aim of our research was to investigate the relationship 
between haematological parameters, biochemical markers of 
iron metabolism and trace elements in children under 3 years 
with IDA. 
2. Materials and Methods 
2.1. Investigation Design 
Our investigation comprises 86 patients from 0 to 3 years 
of age with clinical and laboratory signs of IDA. 38 children 
are patients of the University Hospital, Medical University – 
Pleven, Bulgaria – I group, and 48 are patients of the Sumy 
Regional Child’s Clinical Hospital, Sumy, Ukraine – II group.  
Comparison group includes 25 healthy children at the same 
age. 
All children were enrolled in the study after informed 
consent from their parents or guardians. Ethical approval was 
obtained from the Institutional research ethics committees. 
WHO haemoglobin thresholds were used to identify 
patients as anaemic (haemoglobin level < 110 g/l). IDA was 
defined as haemoglobin values less than WHO guidelines 
with the presence of two or more of the following parameters: 
low mean corpuscular volume (MCV), serum ferritin below 
12 µg/l, and transferrin saturation (SatTf) less than 16% [33]. 
2.2. Blood Sampling 
Fasting venous blood samples were obtained for analysis 
in the morning from all children into sterile tubes untreated 
with heparin, EDTA, citrate, etc. After two hours standing 
and centrifugation at 3500 rpm for 10 minutes, blood serum 
was separated. The serum samples were put in closed plastic 
laboratory vessels for haematological analysis or stored at – 
18ºC until trace element analysis. 
2.3. Haematological Analysis 
Haematological parameters – haemoglobin (Hb), 
haematocrit (Ht), red blood cell (erythrocyte) count (RBC), 
and the red cell indices mean corpuscular volume (MCV), 
mean corpuscular haemoglobin (МСН), mean corpuscular 
haemoglobin concentration (МСНС), and red cell 
distribution width (RDW), were examined by analyzer 
MICROS – 18 (ABX). The reticulocyte count was 
determined by microscopic examination of a peripheral blood 
smear stained with a supravital dye. 
The serum erythropoietin (EPO) levels were determined 
by ELISA using a kit of reagents "Pro Con EPO HS" 
produced by "Protein Contour" (Russia), and serum ferritin 
levels – with the same methods using a kit of reagents "UBI 
MAGIVEL FERRITIN" produced by "United Biotech Inc." 
(USA). 
2.4. Trace element Analysis 
In I group, serum content of trace elements iron, zinc, 
copper, and chromium was determined 
spectrophotometrically: ferozine method [34] for serum iron 
by COBAS INTEGRA 400 (Roche) analyzer, 
spectrophotometric methods using GIESSE diagnostics (Italy) 
tests for serum zinc and AUDIT diagnostics (Ireland) tests 
for serum copper, and spectrophotometric method [35] with 
our modifications for serum chromium. Serum 
concentrations of zinc, copper, and chromium were 
determined by a spectrophotometer DR2800 (Hach Lange, 
Germany). 
In II group, the content of trace elements iron, zinc, copper, 
cobalt, and nickel in blood serum and erythrocytes was 
determined by atomic absorption spectrophotometry (AAS) 
on a spectrophotometer C-115M1 (JSC "Selmi", Ukraine) [36, 
37]. 
2.5. Statistical Analysis 
Statistical data processing was performed using statistical 
packet SPSS v. 13.0 and Excel for Windows. Statistical 
significance was indicated by p-values < 0.05. To evaluate a 
relationship between biochemical markers of iron 
metabolism and haematological parameters we have used a 
correlation analysis with calculation of the correlation 
coefficients by Spearman. 
3. Results and Discussion 
Results of investigated clinical laboratory indicators in 
patients with IDA and the respective reference values are 
presented in table 1. All key haematological indicators of 
anaemic children are significantly lover that the control 
group. Low serum trace element concentrations of zinc, 
copper, cobalt, and nickel, mainly due to inadequate dietary 
intake, malabsorption problems, and trace element 
interactions, were found in both studied groups (I and II 
group) of children with IDA. Profiles of trace elements iron 
and zinc in blood serum do not differ in the two examined 
groups by the means of two analytical methods applied. 
Increased serum concentrations of copper in II group in 
comparison to control subjects are probably due to metabolic 
changes resulting from adaptation mechanisms in IDA. 
In order to study the causes for trace element deficiencies 
of iron, zinc, copper, and chromium in children with IDA, as 
well as the influence of trace element status of zinc, copper, 
and chromium on the development of IDA, we have 
investigated the relationship between markers of trace 
element status, serum concentrations of macroelements, and 
haematological parameters as continuous quantitative 
variables. 
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Table 1. Haematological parameters and content of trace elements in blood serum and erythrocytes of children with IDA. 
Parameter I group with IDA (n=38) II group with IDA (n=48) Comparison group (n=25) 
Haemoglobin (g/l) 86.87±14.06* 89.79±1.23* 119.15±2.41 
Haematocrit (l/l) 0.276±0.031* 0.301±0.004 0.3442±0.006 
RBC (×1012 cells/l) 4.51±0.61* 3.58±0.05 4.07±0.12 
Rtc (‰) – 5.5±0.87* 7.86±0.98 
MCV (fl) 62.03±10.18* 74.66±1.08 82.52±1.17 
MCH (pg) 19.97±4.26* 24.77±0.39 29.82±0.56 
MCHC (g/l) 318.92±19.95* 323.47±4.34 365.17±3.6 
RDW (%) 16.18±2.07 – – 
WBC(×109/l) 11.75±4.4* 6.3±0.81 6.5±0.59 
PLT (×109/l) 467.68±163.11* 250.8±22.7 243.2±21.6 
Serum Fe (µmol/l) 4.01±1.36* 9.23±0.86* 22.92±1.83 
TIBC (µmol/l) 79.22±16.91 – – 
SatTf (%) 5.19±2.25 – – 
Erythrocyte Fe (mcg/mg ash) – 15.58±1.13* 31.56±1.65 
Serum ferritin (ng/ml) – 9.42 ± 0.75* 38.67 ± 4.18 
Serum erythropoietin, (mU/ml) – 32.67 ± 2.49* 15.29 ± 4.26 
Serum zinc (µmol/l) 10.62 ± 4.37* 11.02±1.79* 17.96±1.06 
Serum copper (µmol/l) 11.42 ± 3.97* 23.80±0.76* 16.50±0.71 
Serum chromium (µmol/l) 0.93 ± 0.67 – – 
Serum cobalt (µmol/l×10-3) – 5.74±0.76* 9.16±0.61 
Serum nickel (µmol/l×10-3) – 8.99±0.868* 14.35±1.09 
Notes: * Significantly different from the control group, р<0.05. 
Table 2. Results of correlation analysis of the relationship between biochemical markers of iron metabolism and haematological parameters in children with 
IDA. 
Indicator 
Serum Fe (µmol/l), 
n = 38 
TIBC (µmol/l), 
n = 38 
SatTf (%), 
n=38 
Erythrocyte Fe 
(mcg/mg ash), n=48 
Serum ferritin 
(ng/ml), n=48 
Serum erythropoietin, 
(mU/ml),  n=48 
Hb (g/l) 0.361** -0.448** 0.468** 0.822** 0.514** -0.814** 
Hct (l/l) 0.263** -0.299** 0.325** 0.641* 0.191 -0.535* 
RBC(×1012/l) - 0.180* 0.341** -0.307** 0.410* -0.525* -0.275 
MCV (fl) 0.401** -0.635** 0.598** 0.728** 0.831** -0.070 
MCH (pg) 0.402** -0.646** 0.602** 0.835** 0.601** -0.616* 
MCHC (g/l) 0.322** -0.501** 0.471** 0.219 0.178 0.229 
RDW (%) -0.372** 0.324** -0.430** 0.283 -0.452* -0.154 
WBC(×109/l) -0.167* -0.198** -0.073 0.134 0.589* -0.176 
PLT (×109/l) -0.302** 0.239** -0.325** 0.365* 0.651* 0.021 
Notes: * Significance level, р<0.05;  
** Significance level, р<0.01. 
We found statistically significant correlations between 
biochemical markers of iron metabolism ‒ serum and 
erythrocyte iron, TIBC, transferrin saturation, and serum 
ferritin, and haematological parameters ‒ haemoglobin, 
haematocrit, RBC count, RBC indices ‒ MCV, MCH, MCHC, 
and RDW, in studied patients with IDA (Table 2). It is worthy 
of note that the correlations of markers of iron metabolism 
with haemoglobin, RBC indices MCV and MCH are strong. 
In parallel with lowering the values of serum and 
erythrocyte iron, serum ferritin, and SatTf, and increasing of 
TIBC, a decrease in values of haematological parameters Hb, 
Hct, MCV, MCH, and MCHC was observed with progression 
of ID. Serum iron, serum ferritin and SatTf showed negative, 
TIBC and erythrocyte iron ‒ positive correlations with the 
RBC count and the RBC index RDW (Table 2). 
There were statistically significant weak negative 
correlations between WBC count and serum level of iron, 
and WBC count and TIBC, but positive strong between WBC 
and serum ferritin. Observed statistically significant 
correlations between laboratory parameters of iron 
metabolism and platelet count were negative weak for serum 
iron, weak positive for TIBC, and negative moderate for 
transferrin saturation. A positive strong correlation between 
platelet count and serum ferritin was observed (Table 2). 
Level of serum erythropoietin which is a main regulator of 
RBC production, had statistically significant negative 
correlations with haemoglobin, haematocrit and such RBC 
indices as MCH. 
Statistically significant correlations between biochemical 
markers of iron metabolism (serum iron, transferrin 
saturation, erythrocyte iron, serum ferritin) and 
haematological parameters Hb, Hct, red cell indices express 
the progression of anaemia severity and changes in RBC 
morphology, in parallel with development of ID. The 
relationship between severity of ID and reduction in RBC 
size (microcytosis), and haemoglobin content of the RBC 
(hypochromia), quantitatively determinable with RBC 
indices MCV and MCH is most pronounced. In a document 
of the WHO (2001), it is reported that MCV and MCH are 
the most sensitive indicators for ID from RBC indices [38]. 
The elevation in values of RDW with increasing severity 
of ID reflects the presence of anisocytosis ‒ differences in the 
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size of RBC (Table 1). According Thomas (2005), RDW is 
markedly increased with worsening of ID [39]. The negative 
sign of the relationship between indicators of iron status SFe 
and SatTf, and the RBC count (Table 1) is probably related to 
the mean value of RBC above the lower limit of the reference 
values, which is observed in the study group of patients. 
Observed correlations between TIBC and haematological 
parameters Hb, Hct, RBC count, RBC indices have opposite 
signs to relationships with SFe and SatTf. This reflects the 
elevation in values of TIBC with progression of ID, due to 
increase in unoccupied binding sites on plasma transferrin 
[40, 41] 
Negative correlation between TIBC and WBC count may 
be explained by the increase in the value of WBC in 
infectious processes, which are involved in the development 
of anaemia with normal or reduced TIBC [42]. Negative 
correlation between SFe and WBC count may be explained 
by lowering serum levels of iron in conditions of infectious 
processes mediated by the hormone hepsidin [43-45]. High 
positive correlation between serum ferritin and WBC may be 
related to the role of ferritin in the acute phase response [46, 
47]. In the absence of inflammation, the concentration of 
SFR describes the size of the total body iron stores. Normal 
or slightly decreased WBC count together with low serum 
ferritin level is typical for IDA [48]. 
In the studied patients, progression of ID is associated with 
an increase in platelet count. In iron-deficient conditions, 
stimulation of erythropoiesis with increased production of 
erythropoietin occurs [49]. This molecule has a structural 
homology with thrombopoietin and cross-reacts with the 
megakaryocyte receptor of thrombopoietin [41]. Absence of 
correlations between sEPO, RBC and PLT in anaemic 
children may be due to deficiencies of other micronutrients 
needed for proper formation of erythrocytes and platelets, 
such as zinc, copper, chromium, etc. 
At the same time, high levels of sEPO typical for children 
with IDA negatively correlate with the level of haemoglobin, 
haematocrit and MCH. In anaemic patients hypoxia and iron 
depletion induce increase in erythropoietin synthesis and 
marked suppression of hepcidin [50]. But if serum hepcidin 
is still elevated, it suppresses intestinal iron uptake and 
violates the normal haemoglobin synthesis [51]. 
According to the aim of our research, we examined the 
relationship between serum concentrations of particular trace 
elements ‒ zinc, copper, chromium, cobalt, and nickel, as 
well as the relationship between serum levels of trace 
elements and biochemical markers of iron metabolism, 
macroelements and haematological parameters. 
Table 3. Correlations between serum levels of trace elements, biochemical markers of iron metabolism and macroelements in group I (n = 38) and group II (n 
= 48) patients. 
Group I 
Micronutrient Indicator Correlation coefficient, r Significance level, р 
SFe (µmol/l) SNa (mmol/l) 0.357 0.028 
SFe (µmol/l) SК (mmol/l) -0.307 0.061 
SZn (µmol/l) SNa (mmol/l) 0.343 0.035 
SCr (µmol/l) SFe (µmol/l) -0.318 0.052 
SCr (µmol/l) ТIBC (µmol/l) 0.302 0.065 
SCr (µmol/l) SatTf (%) -0.382 0.018 
Group II 
Micronutrient Indicator Correlation coefficient, r Significance level, р 
SFe (µmol/l) SZn (µmol/l) 0.611 0.016 
SFe (µmol/l) SCu (µmol/l) -0.854 0.0005 
SFe (µmol/l) SCo (µmol/l) 0.209 0.513 
SFe (µmol/l) SNi (µmol/l) 0.084 0.776 
SFe (µmol/l) SFR (ng/ml) 0.785 0.0003 
SFe (µmol/l) SEPO (mU/ml) 0.768 0.0005 
SZn (µmol/l) SCu (µmol/l) -0.614 0.046 
SZn (µmol/l) SCo (µmol/l) 0.229 0.354 
SZn (µmol/l) SNi (µmol/l) 0.015 0.886 
SZn (µmol/l) SFR (ng/ml) 0.336 0.221 
SZn (µmol/l) SEPO (mU/ml) 0.543 0.036 
SCu (µmol/l) SCo (µmol/l) -0.798 0.0004 
SCu (µmol/l) SNi (µmol/l) -0.065 0.831 
SCu (µmol/l) SFR (ng/ml) -0.561 0.029 
SCu (µmol/l) SEPO (mU/ml) -0.739 0.0016 
SCo (µmol/l) SNi (µmol/l) 0.900 0.0001 
SCo (µmol/l) SFR (ng/ml) 0.319 0.289 
SCo (µmol/l) SEPO (mU/ml) 0.769 0.0021 
SNi (µmol/l) SFR (ng/ml) -0.258 0.394 
SNi (µmol/l) SEPO (mU/ml) 0.275 0.364 
 
In the studied group of children with IDA (n = 38), we 
found a moderate positive correlation between serum levels 
of zinc and sodium (r = 0.343; p = 0.035), a moderate 
positive correlation between serum levels of iron and sodium 
(r = 0.357; p = 0.028), a moderate negative correlation 
between serum levels of iron and potassium (r = -0.307; p = 
0.061), and correlations between serum levels of chromium 
and biochemical markers of iron metabolism. Relationships 
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described were statistically significant or close to the 
statistical significance. The results obtained are shown in 
Table 3. 
In parallel with progression of ID presenting with 
reduction in SFe and SatTf, and increase in TIBC, there was 
an increase in serum chromium. 
Trace elements zinc and iron, macronutrients sodium and 
potassium are received in the organism by the food. Common 
causes for their insufficiencies in the studied patients are 
diseases with presence of malabsorption syndrome. It was 
found that malabsorption increases significantly risk for iron, 
zinc, and copper insufficiencies in affected subjects [52, 53]. 
The positive correlation between SFe and serum sodium 
found was due to the synergism between the two metals, 
since the insufficiencies of synergistically interacting with 
the iron minerals lead to development of ID [54]. In patients 
with malabsorption, mean serum levels of both minerals are 
below the lower limits of the reference ranges. In the 
literature, there is evidence of synergistic interactions 
between iron and potassium [54]. The correlation between 
their serum levels, which we observed, is negative. The 
direction of this relationship may be attributed to observed 
values of serum potassium within the reference values, even 
in patients with clinically manifested malabsorption 
syndrome. 
We consider that the positive correlation between serum 
zinc and sodium is due to co-existing insufficiencies of both 
minerals in patients with malabsorption, in which their mean 
serum levels were below the lower limits of the reference 
ranges. 
In studied patients with IDA, increasing in serum 
chromium with the progression of ID is observed. It is well-
known that between the trivalent chromium and trivalent iron, 
there is a competitive antagonism for binding to apo-
transferrin in the serum [54, 55]. In a study on male 
volunteers, negative effects of chromium-containing 
preparations on iron metabolism and status in long-term and 
high dose application are hypothesized [56]. In confirmation 
of this interaction, Ani and Moshtaguie (1992) reported a 
significant decrease in the values of SFe, TIBC, serum 
ferritin, Hb, and Hct after administration of chromium in 
experimental animals. 
Both metals zinc and copper demonstrate statistically 
significant correlations (positive and negative, respectively) 
with iron, due to their important role in the absorption and 
metabolism of iron. The serum zinc level was significantly 
altered in children with iron deficiency, in whom zinc 
protoporphyrin is produced instead of haem and is 
consequently increased in erythrocytes. Measuring zinc 
protoporphyrin together with ferritin and haemoglobin can be 
used to assess the degree of iron deficiency [23]. The copper 
containing protein, ceruloplasmin, is the link between copper 
and iron metabolism. Oxidation of ferrous iron is greatly 
accelerated (10-100 fold) by ceruloplasmin ferroxidase [57]. 
Negative correlation with iron might be a result of the fact 
that copper is insufficiently used and accumulates 
excessively in tissues during iron deficiency. In experiments 
with iron deficiency, increases of the level of some trace 
elements like copper have been observed [58]. Similar results 
were found among children [12]. Conversely, severe copper 
deficiency in humans provokes iron accumulation in the liver, 
due to the absence of ferroxidase activity [57]. 
Iron stores in the liver, spleen, and bone marrow exist 
primarily in the form of ferritin. That’s why the concentration 
of serum ferritin is positively correlated with the serum iron 
and the size of the total body iron stores [46]. 
Positive correlation of iron and erythropoietin shows their 
interaction and influence on the stem cells along the 
erythroid line. Iron is necessary for the production of new 
haemoglobin on the pro-erythroblast stage. Erythropoietin 
promotes the maturation of burst-forming unit ‒ erythroid's 
into colony-forming unit ‒ erythroid's and subsequently into 
mature erythrocytes. If erythropoietin is present without 
sufficient iron, there is insufficient material for red cell 
production [59]. 
Zinc competes with copper in the processes of absorption 
in the intestine, which may explain the presence of a negative 
correlation between these trace elements [23]. A study done 
by Turgut et al. have also found a decrease in serum Zn level 
and an increase in serum Cu level in the anaemic group [12]. 
Patients with IDA due to continuous hypoxia may 
demonstrate supraphysiological level of erythropoietin [60, 
61]. In case of IDA, erythropoietin stimulates production of 
protoporphyrin IX, the precursor of the haem, but the iron 
that normally is inserted into the protoporphyrin lacks. Zinc, 
the second most abundant divalent cation in the red cells, fills 
the void for forming zinc protoprophyrin. However, zinc 
protoporphyrin does not function in oxygen delivery by 
haemoglobin, that's why hypoxia and erythropoietin 
production continue [62]. 
Copper is one of the main negative regulators of 
erythropoiesis in children with IDA. This element 
demonstrates statistically significant negative correlations 
with serum iron, zinc (as mentioned above), but also with 
cobalt, as well as serum ferritin and erythropoietin. 
However, copper in the form of ceruloplasmin influences 
the oxidation of ferrous iron into ferric state [11]. These 
processes are important for iron stores and ferritin formation. 
In anaemic patients with depletion of iron stores high 
ceruloplasmin activity is ineffective. On the one hand, it does 
not increase ferritin level, on the other – may provoke 
elevation of oxidative blood ability and cause lipid 
peroxidation [63].  
Erythropoietin is not only erythropoiesis stimulator, but 
also an anti-apoptotic, anti-inflammatory substance that has 
protective properties against oxidative stress, and modulatory 
effects on Cu and Zn levels [64]. Negative correlation 
between erythropoietin and copper in children with IDA may 
be related to the high activity of ceruloplasmin. 
Cobalt and copper are absorbed by similar transport 
mechanisms [65] and the competition between them 
contributes to a negative correlation. 
Positive impact of cobalt on the erythropoietin production 
is associated with the following mechanisms. Cobalt 
 Health Sciences Research 2014; 1(4): 58-67  64 
 
stimulates erythropoietin production by activation of the 
transcription factor hypoxia-inducible factor-1α (HIF-1α) and 
HIF-2α [66]. The results of such influences are acceleration 
of maturation of erythroid stem cells and stimulation of 
haemoglobin synthesis [67]. One International erythropoietin 
Unit (IU) elicits the same erythropoiesis-stimulating activity 
as 5 µmol Co2+ [68].  
Our investigation shows that both cobalt and nickel have 
indirect mechanisms of influence on the iron metabolism. 
Positive interaction with cobalt and other mechanisms may 
play role here. For example, the levels of other minerals, 
such as magnesium, zinc and calcium may alter nickel 
absorption from the gut [69]. Nickel induces the synthesis of 
phosphatidylserine, which stabilizes the membrane of 
erythrocytes and prolonges their life. Significant amounts of 
nickel are found in RNA and DNA, where nickel interacts 
with these nucleic acids and that’s why may influence on the 
erythroblasts growth. Most of the plasma nickel is a 
constituent of the circulating proteins nickeloplasmin and 
albumin, and it is also thought to be a factor in a hormone 
(erythropoietin), and cell membrane metabolism [31]. Nickel 
deficiency increases the excretion of iron ions from the 
human body [70].  
Results of our work suggest that serum zinc, copper, cobalt 
and nickel interact with iron, haematological parameters of 
iron metabolism and with each other in children with IDA. 
The differences observed might be attributed to relations 
between iron and different elements at the absorption, 
transport, and storage. 
4. Conclusion 
Correlations between haematological parameters 
(haemoglobin, haematocrit, red blood cells), erythrocyte 
indexes (MCV, MCH, MCHC) and biochemical markers of 
iron metabolism describe leader role of iron in erythropoiesis 
in children with IDA. But formation of IDA is caused not 
only by violation of iron metabolism, but also by interactions 
with other trace elements that may affect directly or 
indirectly both the iron exchange and erythropoiesis 
regulation through the erythropoietin production. 
Thus, we found a significant correlations between the level 
of chromium and SatTf (r = -0.382, p = 0.018), zinc – with 
SEPO (r = 0.543, p = 0.036), copper – with SFR (r = -0.561, 
p = 0.029), and SEPO (r = -0.739, p = 0.0016), and cobalt – 
with SEPO (r = 0.769, p = 0.0021), that indicate the role of 
trace elements in the pathogenesis of IDA. 
Some trace elements play significant roles in 
haematopoiesis and iron metabolism. Their failure or excess 
may lead to alteration in haem metabolism and provoke 
anaemia. We found that some trace element insufficiencies 
(zinc, cobalt, and nickel) develop in children with iron 
deficiency anaemia, but the question about serum copper 
level is still open. There is insufficiency of copper in some 
patients, while excess of copper in the blood is observed in 
other populations of children. Deficiencies or interactions 
between trace elements may cause disorders in the absorption, 
distribution, metabolism and elimination of other trace 
elements. Two main microelements (zinc and copper) can 
directly influence on the iron metabolism. Mechanism of 
other trace elements action (cobalt, nickel, chromium) is 
more complex. It is associated with a mediated effect, i.e. by 
other trace elements, including the processes of transport, 
deposition of iron, etc. 
Thus, if the routine therapy of IDA is ineffective, a 
concomitant micronutrient disorder should be considered, 
with an evaluation of trace elements level, and, if necessary, 
a correction should be carried out. 
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